Home / Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses
Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses
Pfister C.,
Gravis G.,
Flechon A.,
Soulie M.,
Guy L.,
Laguerre B.,
Mottet N.,
Joly F.,
Allory Y.,
Harter V.,
Culine S.,
GETUG AFU V05 Investigators
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
